Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer

Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer

Abstract The left ventricular trabecular fractal dimension (LVTFD) derived from cardiac magnetic resonance reflects myocardial trabecular complexity, which is associated with cardiovascular disease risk. Baseline risk stratification of cancer therapy–related cardiac dysfunction (CTRCD) in patients w...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hesong Shen, Qian Xu, Chunrong Tu, Yangling Peng, Yuhang Xie, Zhiming Miao, Rui Yang, Jiuquan Zhang
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	MedComm
Subjects:	breast cancer cardiotoxicity magnetic resonance imaging
Online Access:	https://doi.org/10.1002/mco2.70004
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy
by: Kai Tao, et al.
Published: (2025-02-01)

Cardiorespiratory fitness, cardiac morphology and function, and cardiovascular risk factors in long-term breast cancer survivors compared with non-cancer controls
by: Mali Sæter, et al.
Published: (2025-01-01)

The association of BMI and subclinical myocardial dysfunction in breast cancer patients after single or dual anti-HER2 targeted therapy
by: Feng Zhang, et al.
Published: (2024-12-01)

Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer
by: Tytti-Maria Uurasmaa, et al.
Published: (2025-01-01)

Serum cardiac and inflammatory biomarker levels following chemotherapy among female patients with breast cancer attending at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
by: Muluabay Getie, et al.
Published: (2025-01-01)

A multicenter retrospective study of early cardiac toxicity in operable breast cancer patients receiving concurrent dual or mono anti-HER2 therapy with postoperative radiation therapy
by: Jing Yang, et al.
Published: (2025-02-01)

Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs
by: Xiang Zhang, et al.
Published: (2025-02-01)

Evaluation of miR-146a as a potential biomarker for diagnosis of cardiotoxicity induced by chemotherapy in patients with breast cancer
by: Nasrin Zare, et al.
Published: (2025-01-01)

Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function
by: Maor Tzuberi, et al.
Published: (2025-01-01)

Prognosis and cardiotoxicity associated to adjuvant trastuzumab for breast cancer: real world study in a public health system
by: Ana Elisa Ribeiro da Silva Cabello, et al.
Published: (2025-01-01)

Magnetic resonance imaging quantification of left ventricular mechanical dispersion and scar heterogeneity optimize risk stratification after myocardial infarction
by: Xiaoying Zhao, et al.
Published: (2025-01-01)

Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
by: Koichi Egashira, et al.
Published: (2022-06-01)

Investigation of cardiotoxic effects of marbofloxacin
by: Devran Coşkun, et al.

Cardiac involvement in Scorpion envenomation: A review of literature
by: Mitrakrishnan Rayno Navinan, et al.
Published: (2025-01-01)

The Role of Advanced Cardiac Imaging in Monitoring Cardiovascular Complications in Patients with Extracardiac Tumors: A Descriptive Review
by: Annamaria Tavernese, et al.
Published: (2024-12-01)

Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane
by: Marijke Linschoten, et al.
Published: (2025-01-01)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Epigenetic profiling for prognostic stratification and personalized therapy in breast cancer
by: Xiao Guo, et al.
Published: (2025-01-01)

Cardiac Markers in Pediatric Laboratory Medicine: Critical Review
by: Renata Zrinski Topic, et al.
Published: (2025-01-01)

A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosis
by: Junyue Xing, et al.
Published: (2025-01-01)

Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients
by: Alessandra Cuomo, et al.
Published: (2022-06-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213)
by: Arnethea L. Sutton, et al.
Published: (2025-02-01)

Ventricular Depolarization Abnormalities and Their Role in Cardiac Risk Stratification — A Narrative Review
by: Maarten Blondeel, et al.
Published: (2025-01-01)

Analysis of the cardiotoxic and myorelaxant effects of camphor on fish of the Nile tilapia species (Oreochromis niloticus) (Linnaeus 1758)
by: Clarissa Araújo da Paz, et al.
Published: (2025-01-01)

The Impacts of Cardiac Rehabilitation Program on Echocardiographic Parameters in Coronary Artery Disease Patients with Left Ventricular Dysfunction
by: Masoumeh Sadeghi, et al.
Published: (2013-01-01)

Prognostic Value of Left Ventricular Diastolic Dysfunction in Patients Undergoing Cardiac Catheterization for Coronary Artery Disease
by: Hidekatsu Fukuta, et al.
Published: (2012-01-01)

Left Ventricular Hypertrabeculation (LVHT) in Athletes: A Negligible Finding?
by: Rokas Jagminas, et al.
Published: (2024-12-01)

Factors Associated With the Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Left Ventricular Dysfunction
by: Tyler Shugg PharmD, PhD, et al.
Published: (2025-01-01)

Novel molecular biomarkers of cancer therapy‐induced cardiotoxicity in adult population: a scoping review
by: Irene Cartas‐Espinel, et al.
Published: (2022-06-01)

The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction
by: Alberto Palazzuoli, et al.
Published: (2013-01-01)

Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
by: Bowen Yin, et al.
Published: (2025-01-01)

Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Population
by: Wang RH, et al.
Published: (2025-02-01)

A meta-analysis of the association between preoperative magnetic resonance imaging and surgical outcomes in newly diagnosed breast cancer
by: Li-Li Xie, et al.
Published: (2021-04-01)

Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
by: Caroline Schoenherr, et al.
Published: (2025-01-01)

Effect of preoperative right ventricular dysfunction and dilatation on survival after left ventricular surgical restoration
by: Abdelhameed Elsayed, et al.
Published: (2025-01-01)

Determining the Diagnostic Value of DWIBS in the Diagnosis of Breast Lesions Compared to Dynamic Contrast-Enhanced MRI: A Retrospective Observational Study
by: Maryam Farghadani, et al.
Published: (2025-01-01)

Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy
by: Xin-Yi Feng, et al.
Published: (2025-01-01)

Cardiotoxicity of polystyrene nanoplastics and associated mechanism of myocardial cell injury in mice
by: Ziyi Xiong, et al.
Published: (2025-01-01)